How Challenges in Biologics Development Catalyze Innovations in Cell Line Development
NGS for Automated & Regulatory-Compliant Monitoring of CQAs in Biologics
AI-Driven & GMP-Compliant Digital Infrastructure for NGS-Based Assays
Industry Perspectives on Preparing Validation-Ready NGS Workflows
Alison Waterfield May 17, 2026
Driving Biopharma Automation and AI
Unlocking NGS and Regulatory Synergy in GCT for Maximum Impact
NGS for Product Characterization in CGT: Biosafety and Genome Integrity
From Science to Compliance: Effective Validation of Genedata Selector
Genedata for Developability Across Biopharma R&D
Genedata Biopharma Platform: Compliance-Ready
Lessons Learned from a Full-Scale GMP Validation of NGS Workflows
Unified Platform for Assay Development and GMP‑Ready NGS Analytics In-House
NGS‑MAM Framework for Comprehensive Vector Characterization
Automated NGS Data Analysis in AAV Upstream Manufacturing
NGS Made Practical: Meeting European Pharmacopoeia Standards
March 30, 2026
Genedata Flexible Deployment for Any Digital Ecosystem.
Genedata Selector Product Development Roadmap
Genedata’s Unparalleled Partner Symposium, 2026 Edition
March 12, 2026
In-and-Out Characterization and CQA Monitoring of AAVs
Boehringer Ingelheim Accelerates NGS-Driven Cell Line Characterization
The Real Benefits (and Remaining Barriers) to AI in Biopharma
Mark Brewer, PhD, Ada Yee, PhD February 19, 2026
From Screening to Sequencing: Digital Backbone for Antibody Discovery
Accelerating CMC with NGS through AI-Driven and GMP-Compliant Digital Infrastructure
NGS Data Analysis Automation for R&D & QC
Raed Hmadi February 6, 2026
Automated and Scalable NGS Data Analysis
Genedata Selector
Mastering NGS Assay Validation for GMP: Why It Matters for Cell and Gene Therapy
Ludwig Macko, Valentina Armiento January 19, 2026
Multi-Omics Analysis for Resistance Mode-of-Action Discovery
Visualization of Pangenome Data for Crop Breeding R&D
Digitalizing Trait Stability in Plant Breeding
Maximize ROI by 11x with In-House NGS
GMP-Validated. NGS Solutions. In-House.
Do The Math: The Unrealized ROI In Lab Automation
Jana Hersch November 14, 2025
NGS in GMP Manufacturing: Reducing Risk, Increasing Return
Christoph Bredack November 6, 2025
NGS-Based Assays for CGT Development
Marie-Ange Kouassi October 23, 2025
Enhancing Gene Therapy Assets with GMP-Ready NGS Assays
Industry Experiences in Bringing NGS-Based Workflows In-House
Alison Waterfield September 29, 2025
Rapid Contamination Identification with Nanopore Sequencing
Automating Adventitious Agent Detection for GMP and Lot Release
Reinvent Biopharma. Automation & AI.
NGS Analyses. GxP-Ready. Unlimited.
